Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).

Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).

The present invention relates to brominated polyether polyols, processes for the production as well as intermediates useful in the production of the same and to processes for the preparation of flame-retardant blends, premixes as well as polyurethane foams.

The present invention relates to a method of preparing ortho substituted phenols from 2,5-dimethylfuran and propargyl ethers in the presence of a gold(I) complex. It is particularly advantageous to use 2,5-dimethylfuran as this offers an ecological beneficial synthesis of said ortho substituted phenols.

Macromolecules comprising triazoles and related compositions and methods are provided. In some embodiments, a macromolecule may comprise one or more repeat units including a triazole and a functionalizable pendant group. The macromolecule may also comprise one or more orthogonally addressable end groups. In some embodiments, one or more repeat units may be formed by a synthetic process that allows for precise control over stereochemistry, pendant functionality, and/or the spatial relationship (e.g., distance) between groups in the repeat unit(s). Such precise control over pendant group and repeat unit structure allows for the macromolecule functionality, stereochemistry, and spacing between groups (e.g., pendant groups) to be precisely controlled. Macromolecules described herein may be used for a wide variety of applications, including the delivery of active agents.

The present disclosure provides a composition comprising a surfactant compound containing aromatic groups in the hydrophobe. Also disclosed are personal care formulations and performance chemical formulations, such as agrochemical formulations, that comprise such surfactant compounds.

A fluorine-containing ether compound represented by Formula (1) is provided;

R.sup.1R.sup.2CH.sub.2R.sup.3CH.sub.2R.sup.4R.sup.5(1)

(In Formula (1), R.sup.1 and R.sup.5 may be the same as or different from each other and each represents an alkenyl group having 2 to 8 carbon atoms or an alkynyl group having 3 to 8 carbon atoms, R.sup.2 and R.sup.4 may be the same as or different from each other and each represents a divalent linking group having a polar group, and R.sup.3 represents a perfluoropolyether chain, with a proviso that R.sup.1 and R.sup.2 are, and R.sup.4 and R.sup.5 are divided due to the presence of an atom other than the carbon atom such as an oxygen atom).

The present invention provides a fluorine-containing ether compound represented by the following Formula. R.sup.1-[B]-[A]-CH.sub.2R.sup.2CH.sub.2-[C]-[D]-R.sup.3 (R.sup.2 is a perfluoropolyether chain; [A] is Formula (2-1); [B] is Formula (2-2); [C] is Formula (3-1); [D] is Formula (3-2); R.sup.3 is Formula (4); and R.sup.1 is a terminal group.)

##STR00001##

Compounds of Formula I or II, methods of preparation and of use thereof. Formula I has a core aromatic group with substituents as follows: Formula (I) wherein G.sub.1 is (CH.sub.2).sub.nC(R.sub.1)(R.sub.2)OH, (CH.sub.2).sub.n; CHO, (CH.sub.2).sub.nC(O)NR.sub.1R.sub.2, (CH.sub.2).sub.nCH (R.sub.1)NR.sub.1R.sub.2, (CH.sub.2).sub.nC(O)OR.sub.3, (CH.sub.2).sub.nCH(R.sub.1)OR.sub.3, or (CH.sub.2).sub.nC(O)R.sub.3; G.sub.2 and G.sub.4 are independently H, OH, F, or Cl, where G.sub.2 can also be NH.sub.2; G.sub.3 and G.sub.5 are independently (H, F, Cl, OH, (CH.sub.2).sub.n-optionally substituted heterocycle, (CH.sub.2).sub.n-optionally substituted phenyl, (CH.sub.2).sub.nC.sub.3H.sub.5, optionally substituted C.sub.1-C.sub.6 alkyl, optionally substituted C.sub.2-C.sub.6 alkenyl, C(O)R.sub.3, or CH(OH)R.sub.3; and G.sub.6 is H, F, Cl, OH, (CH.sub.2).sub.n-optionally substituted heterocycle, (CH.sub.2).sub.n-optionally substituted phenyl, or (CH.sub.2).sub.nCOOH, wherein ?n is an integer selected from 0 to 5, ?R.sub.1 and R.sub.2 are independently selected from H and optionally substituted C.sub.1-C.sub.6 alkyl group, and ?R.sub.3 is an optionally substituted C.sub.1-C.sub.6 alkyl group or when present on G.sub.1 forms a lactone with the core aromatic group, or a pharmaceutically acceptable salt thereof.

##STR00001##

Disclosed is an anti-oxidation stabilizer, which has the following structure (A), wherein RI is a connection chain, and the connection chain is a fatty chain, an aromatic structural chain or a fatty and aromatic structurally combined chain; R2 is (B), and X is O, S, N or NH or CONR, Z is O, S, N or NH, and X is different from Z; R is a fatty chain, an aromatic group, a sterically hindered amine or sterically hindered phenol, R3 is a fatty chain, an aromatic group, a sterically hindered amine or sterically hindered phenol, and R is identical to R3, or R is different from R3; n is a positive integer including 1, n1 is a positive integer including 1, and n is identical to n1, or n is different from n1.